Literature DB >> 7731035

The biology of the P-glycoproteins.

C R Leveille-Webster1, I M Arias.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7731035     DOI： 10.1007/bf00234655

Source DB:  PubMed          Journal:  J Membr Biol        ISSN： 0022-2631            Impact factor:   1.843


× No keyword cloud information.
  192 in total

Review 1.  P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.

Authors:  D Nielsen; T Skovsgaard
Journal:  Biochim Biophys Acta       Date:  1992-07-07

2.  Structure and expression of the human MDR (P-glycoprotein) gene family.

Authors:  J E Chin; R Soffir; K E Noonan; K Choi; I B Roninson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  Deletion and insertion mutants of the multidrug transporter.

Authors:  S J Currier; K Ueda; M C Willingham; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

Review 4.  Multidrug resistance mediated by P-glycoproteins.

Authors:  A H Schinkel; P Borst
Journal:  Semin Cancer Biol       Date:  1991-08       Impact factor: 15.707

5.  Coordinate activation of multidrug-resistance (P-glycoprotein) genes mdr2 and mdr3 during mouse liver regeneration.

Authors:  L D Teeter; J Y Chan; M T Kuo
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

6.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation.

Authors:  J T Zhang; V Ling
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

7.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective.

Authors:  J C Shepherd; T N Schumacher; P G Ashton-Rickardt; S Imaeda; H L Ploegh; C A Janeway; S Tonegawa
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

8.  The multidrug resistance (mdr1) gene product functions as an ATP channel.

Authors:  E H Abraham; A G Prat; L Gerweck; T Seneveratne; R J Arceci; R Kramer; G Guidotti; H F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus.

Authors:  R J Arceci; F Baas; R Raponi; S B Horwitz; D Housman; J M Croop
Journal:  Mol Reprod Dev       Date:  1990-02       Impact factor: 2.609

10.  A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

Authors:  J Verweij; H Herweijer; R Oosterom; M E van der Burg; A S Planting; C Seynaeve; G Stoter; K Nooter
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640
View more
  15 in total

1.  Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay.

Authors:  Pengfei Song; Shen Li; Bernd Meibohm; A Osama Gaber; Marsha R Honaker; Malak Kotb; Charles R Yates
Journal:  AAPS PharmSci       Date:  2002

2.  Release of noradrenaline from isolated rat tail artery induced by bafilomycin A1.

Authors:  V Palatý
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

3.  Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.

Authors:  F J Sharom; P Lu; R Liu; X Yu
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 4.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

Review 5.  The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease.

Authors:  Jacque N Wilk; Janine Bilsborough; Joanne L Viney
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 6.  Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.

Authors:  H Lennernäs; G Fager
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

7.  In vitro intestinal permeability of factor Xa inhibitors: influence of chemical structure on passive transport and susceptibility to efflux.

Authors:  N G Schipper; T Osterberg; U Wrange; C Westberg; A Sokolowski; R Rai; W Young; B Sjöström
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

8.  Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

Authors:  G Conseil; H Baubichon-Cortay; G Dayan; J M Jault; D Barron; A Di Pietro
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.

Authors:  Alexia Garrigues; Alexandre E Escargueil; Stephane Orlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

10.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.

Authors:  G J Randolph; S Beaulieu; M Pope; I Sugawara; L Hoffman; R M Steinman; W A Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.